ZTLIDO (nda207962)- (1.8%)

Generic Name	LIDOCAINE	Innovator	SCILEX PHARMS
Dosage	1.8%
ParaIV Filing	Yes	505(b)2 Filing	Yes
Last Patent Expiry	2031-May-10	NCE Excl Expiry	Expired
ODE Expiry	None	NP Expiry	2021-Feb-28
GAIN Expiry	None	Drug Complexity	No
Indication	ZTLIDO contains lidocaine, an amide local anesthetic, and is indicated for relief of pain associated with post-herpetic neuralgia (PHN) in adults.

Approvals and Launches

Final Approvals	Tentative Approvals	Generic Launches
0	0	0

Other Developers

Total Other Developers	4

Drugs with Suitability

Drugs with Suitability	No

Drug Pricing

	NDA			ANDA
Dosage	Weekly	Monthly	Yearly	Yearly Up	Yearly Down
1.8%	**	**	Up	-	-

Drug Sales

NDA Sales Available	Total Generic Sales Available
Yes	0

Manufacturing Details of ZTLIDO